MEDIUM confidence: 100% data completeness, but the composite (44) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Not enough return history to estimate factor exposures — 11 of 36 months required. This stock is too recently listed (or has too short a price history) for a reliable Fama-French regression.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $505M— | $749M+48.4% | $1.1B+41.0% |
| EPS (dil.) | $0.59— | $-3.11-627.1% | $-2.45n/m |
| Free Cash Flow | $1.0B— | -$69M-106.6% | $246Mn/m |
| Gross Margin | 91.2% | 88.3%-2.9pp | 82.4%-5.9pp |
| Operating Margin | -14.5% | -117.1%-102.6pp | -122.2%-5.1pp |
| Net Margin | 56.6% | -97.7%-154.4pp | -118.4%-20.7pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $30 avg across 7 analysts.
Buy-rated share 25% → 40% over ~3 months (+15pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $0.04 | $0.08 | +95.0% |
| May 2026 | $0.06 | $0.10 | +57.9% |
| Feb 2026 | $0.07 | $0.08 | +14.3% |
| Nov 2025 | $0.05 | $0.10 | +119.5% |
| Jul 2025 | $0.08 | $0.18 | +122.5% |
Net insider -$48.8M over 180 days (0 open-market buys, 34 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 27.4%/yr (revenue basis).
Base free cash flow $406M (avg FY2023–FY2025; latest year $246M) · equity value $11.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 44 for FIG suggests a neutral outlook, driven by a mix of strong growth metrics and concerning profitability and value scores. The stock scores high on growth, with revenue growth of 41% and free cash flow growth of 456%, but trades at a premium with a P/S of 9.0. Conversely, it exhibits weak profitability, with an ROE of -108% and an operating margin of -123%, and has negative momentum over the past year, with a 12-month return of -73%. The long-term and short-term scores are relatively close, with the short-term score 6 points higher.